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METHODOLOGY
A suitable palpation technique allows 
to identify skin lipohypertrophic lesions 
in insulin-treated people with diabetes
Sandro Gentile1, Giuseppina Guarino1, Annalisa Giancaterini2, Piero Guida3, Felice Strollo4* and AMD-OSDI 
Italian Injection Technique Study Group
Abstract 
Background: Lipohypertrophy (LH) is a major complication of subcutaneous insulin treatment brought about by 
multiple overlapping injections and/or needle reuse. It is responsible for unacceptable glucose oscillations due to a 
high rate of hypoglycaemic episodes and rebound glucose spikes. Skin ultrasound scans (USS), the gold standard for 
its detection, is too expensive for screening purposes.
Aims: To define a structured method allowing health professionals (HPs) to identify LH lesions as inexpensively and 
correctly as possible.
Methods: Out of 129 insulin-treated people with diabetes identified by USS as having LH lesions, only 40 agreed 
to participate in the study (24 females, age 54 ± 15 years, daily insulin dosage 57 ± 12 IU). Each was blindly exam-
ined by four well trained and four non-trained HPs according to a standard method involving repeated well codified 
maneuvers.
Results: A specific training allowed inexperienced HPs to acquire high diagnostic accuracy in identifying LH lesions 
independent of site, size, shape, and even BMI. This kind of training also allowed to reach a 97 % consistency rate 
among HPs as compared to USS, while the lack of training was associated with a wide variability and inconsistency of 
identification results.
Conclusions: Diabetes teams should follow systematically the simple procedure reported in this paper for the 
diagnosis of LH and try to get it further implemented and progressively refined in large scale studies. This would have 
a major impact on patient education in terms of (1) correct injection technique and (2) ability to identify lesions early 
enough to prevent poor metabolic outcome.
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Background
An appropriate injection technique is essential for optimal 
insulin effect in diabetes mellitus (DM) (Frid et al. 2010). 
Lipodystrophy, including lipohypertrophy (LH) and lipoat-
rophy (LA), is a major complication of subcutaneous insu-
lin shots, LH being by far more frequent than LA.
LH presents itself as a thickened, ‘rubbery’ tissue 
swelling caused by typical growth-enhancing insulin 
properties associated with skin reaction due to multiple 
overlapping injections and/or needle reuse (Thow et  al. 
1990; Richardson and Kerr 2003). Most studies sug-
gest that insulin absorption from sites characterized by 
LH may be both delayed and erratic. As a consequence 
of that, ever increasing doses of insulin are required and 
metabolic control gets worst (Young et al. 1984; Frid and 
Linden 1992; Chowdhury and Escudier 2003; Johansson 
et al. 2005; Gentile et al. 2011). This in turn causes unac-
ceptable glucose oscillations due to a high rate of serious 
hypoglycaemic episodes followed by rebound glucose 
spikes in the cases of patients suddenly switching from 
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altered to normal injection sites. All this has also a strong 
impact on the economic burden of the disease for both 
patients and health care system.
Therefore, it is crucial to try and systematically identify 
as many LH areas as possible in order to educate patients 
to prevent poor insulin injection habits.
Papers published on this topic so far show great differ-
ences in their prevalence in insulin treated patients (see 
Table  1). This is probably due to the lack of a well-struc-
tured diagnostic flow-chart despite the world-wide avail-
ability of suitable ultrasound and radiological methods 
(Seyoum and Abdulkadir 1996; Hauner et al. 1996; McNally 
et al. 1988; Partanen and Rissanen 2000; Raile et al. 2001; 
Kordonouri et al. 2002; Teft 2002; Vardar and Kizilci 2007; 
Hajheydari et al. 2011; Blanco et al. 2013; Grassi et al. 2014). 
Based on these premises, we compared well-trained vs 
untrained health care providers in terms of their ability to 
identify LH lesions of different type, site and size in peo-
ple with diabetes selected by an experienced physician 
and precisely characterized by ultrasound scans (USS).
The final goal of this study was to define a structured 
inexpensive method allowing health professionals (HPs) 




The protocol was prepared according to the Helsinki dec-
laration and approved by the local Ethics Committee.
Consent to publish
Consent to publish was obtained from the participants to 
report their individual data.
Subjects
All patients gave their informed consent for participation 
in the research study.
An experienced physician referring to our clinic exam-
ined 265 people with DM (59 with type 1 DM) who had 
been on insulin for more than one year with at least three 
injections a day of rapid and basal analogues using pre-
filled pens with 5 mm/31 G needles. Patients on human 
insulin or NPH, as well as, those using needles of dif-
ferent length and thickness were intentionally excluded 
from the survey in order to rule out any possible con-
founding factors, because other groups already showed 
that needle length and gauge correlate with the risk of LH 
as well as with the quality of metabolic control (Frid et al. 
2010; Kreugel et  al. 2011; Hansen and Matytsina 2011; 
Blanco et al. 2013).
Out of these 265, 129 people were identified as hav-
ing LH lesions (48.8 %) at one or more injection sites but 
only 40 (45.9  %) agreed to participate in the study. The 
main clinical features of participants are given in Table 2 
and may be briefly summarized as follows: 24 were 
females, age was 54 ± 15 years, daily insulin dosage was 
57 ± 12 IU, all followed a four daily shot regimen.
Methodological aspects of high‑frequency skin ultrasound 
scans
Skin USS were performed at all participants’ injection 
sites to validate the diagnosis of LH and to define single 
lesion features, including size, thickness and texture. USS 
were repeated by different operators on the same patient 
according to the procedure described in the methodology 
section.
High-frequency B-mode skin USS were performed 
invariably using the linear 20 MHz probe (Philips HD3). 
Each specialist performed five consecutive scans of each 
possible site on one day to assess intra-operator variation 
(IntraOV) and on three consecutive days to assess day-
to-day operator variation (D-T-DOV). Moreover three 
different operators performed their scans at 2 h intervals 
between 08:00 and 20:00 h to assess inter-operator varia-
tion (InterOV).
A 100  % consistency in LH identification was found 
among specialists for IntraOV, InterOV and D-T-DOV, 
independently of location, volume, extension, texture or 
thickness. This result confirmed USS to be a gold stand-
ard method for subsequent palpation results.
Study protocol
After being instructed to refrain from revealing their LH 
areas to anyone, all patients were examined by four non-
trained (NT) and four well trained (WT) HPs.
NT HPs were given no advice on how to inspect and 
touch the skin and were simply asked to repeatedly try 







type 1 or 2
Seyoum 1996 31.0 9 1 + 2
Hauner 1996 28.7 10 1
Partanen 2000 34.5 11 1
Raile 2001 27.1 12 1
Kordonouri 2002 48.0 13 1
Vardar 2007 48.8 14 1 + 2
Hajheydari 2011 14.5 15 1 + 2
Teft 2002 57.0 16 1 + 2
Blanco 2013 64.0 17 1 + 2
Grassi 2014 49.0 18 1 + 2
McNally 1988 28.0 19 2
Hauner 1996 3.6 10 2
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and identify lesions in each expected location by examin-
ing the injection sites the best they could.
On the opposite, WT HPs were taught how to correctly 
define LH lesions by performing a careful examination of 
typical injection sites according to the protocol described 
below.
Lesion identification training protocol
The method consisted of the inspection of each inter-
ested area using direct and tangential light against a dark 
background, as well as, of a thorough palpation technique 
(slow circular and vertical finger tip movements followed 
by repeated horizontal attempts on the same spot). HPs 
were also advised to be gentle while touching the skin at 
the beginning and start to progressively increase finger 
pressure thereafter. They were also suggested to perform 
the pinch maneuver when perceiving a harder skin, to 
confirm their first impression by comparing the thickness 
of the suspected spot to that of surrounding areas (Fig. 1). 
Smaller and flatter lesions were best identified by repeat-
ing all above mentioned palpation maneuvers (Fig. 2). 
Statistical analysis
The continuous variables were reported as mean 
value ± Standard Deviation. Between-group comparisons 
made use of the Mann–Whitney test. Categorical varia-
bles were summarized in terms of frequency and percent-
age and the Fisher test was used to evaluate associations 
Table 2 Patient features by lipohypertrophy (LH) site, shape and size
Mean ± standard deviation or rate (percentage). Italics characters are used for statistically significant comparisons (p < 0.05)
Overall Site Shape Diameter
Abdomen Arm Thigh Flat Protruding ≤4 cm >4 cm
n = 40 n = 16 n = 14 n = 10 n = 22 n = 18 n = 20 n = 20
Female gender 60 % 12 (75 %) 8 (57 %) 4 (40 %) 16 (72.7 %) 8 (44.4 %) 10 (50 %) 14 (70 %)
BMI (kg/m2) 29.1 ± 2.4 28.8 ± 3.2 29.7 ± 2.3 28.5 ± 1.2 29 ± 2.1 29.1 ± 2.9 28.8 ± 1.8 29.4 ± 3
LH site
 Abdomen 16 (40 %) 16 (100 %) 0 (0 %) 0 (0 %) 4 (18.2 %) 12 (66.7 %) 2 (10 %) 14 (70 %)
 Arm 14 (35 %) 0 (0 %) 14 (100 %) 0 (0 %) 14 (63.6 %) 0 (0 %) 10 (50 %) 4 (20 %)
 Thigh 19 (25 %) 0 (0 %) 0 (0 %) 10 (100 %) 4 (18.2 %) 6 (33.3 %) 8 (40 %) 2 (10 %)
LH shape
 Flat 22 (55 %) 4 (25 %) 14 (100 %) 4 (40 %) 22 (100 %) 0 (0 %) 16 (80 %) 6 (30 %)
 Protruding 18 (45 %) 12 (75 %) 0 (0 %) 6 (60 %) 0 (0 %) 18 (100 %) 4 (20 %) 14 (70 %)
LH size
 Diameter (cm) 4.8 ± 1.5 10.6 ± 1.2 4.0 ± 1.4 4.8 ± 1.8 4.2 ± 1.3 5.7 ± 1.5 3.6 ± 0.5 6.1 ± 1.1
 Diameter ≤ 4 cm 20 (50 %) 2 (12 %) 10 (71 %) 8 (80 %) 16 (72.7 %) 4 (22.2 %) 20 (100 %) 0 (0 %)
 Diameter > 4 cm 20 (50 %) 14 (88 %) 4 (29 %) 2 (20 %) 6 (27.3 %) 14 (77.8 %) 0 (0 %) 20 (100 %)
Fig. 1 Lipohypertrophy features. Moderate swelling of the abdominal wall below the umbilicus, the site most often chosen by the patient for 
insulin injections; his right hand pinches a thick fold in the presence of a large lipohypertrophy skin plate (a); while only a thin fold results from the 
left hand squeezing the area systematically ignored for insulin shots (b)
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among them. The data repeatedly recorded by WT and 
NT groups were analyzed according to a mixed logistic 
model with patients fitted as random. The mixed model 
provided separate estimates of the proportion of patients 
correctly identified by WT and NT health profession-
als. The association between patients characteristics and 
missed LH identification was evaluated by means of uni-
variate and multivariate logistic mixed models. Odds 
ratios (ORs) were given with their 95 % confidence inter-
vals (CIs). All analyses were carried out using STATA 
software, Version 12 (Stata Corp, College Station, TX, 
USA) with p values <0.05 a priori accepted as significant.
Results
As described in Table  2, LH lesions were found in 16 
patients on the abdomen, in 14 on the arms and in 10 on 
the thighs. 22 lesions were flat and 18 were protruding; 
in 20 the lesion diameter was >4  cm. By analyzing the 
data, a relationship could be found between LH location, 
shape and size, where the smallest lesions were mostly 
flat and located on the arms. Figure 1 shows the appear-
ance of large abdominal LH lesions in an overweight 
patient.
Table 3 shows the results provided by the two groups of 
HPs analyzed with respect to location, thickness and size. 
NT HPs were different in their ability to identify LH, thus 
displaying a diagnostic sensitivity of 72  % (51–87  %) vs 
the 96 % (89–99 %) found in WT HPs.
Figure 3 summarizes the results of the two groups and 
shows lower percentage of correct classifications in the 
NT group in the presence of smaller or flatter lesions, 
especially those occurring at the arm level.
Table 4 shows parameters related to missed LH identi-
fication. The top half of the table describes the analysis of 
data recorded by NT HPs, and the bottom half refers to 
the whole population under study: a significantly higher 
risk of missing LH identification was shown by the NT 
group. The factors associated to missed identification 
were again small size, flat shape and arm location while 
BMI did not affect the results.
Conclusions
An ever increasing number of reports in the literature 
points to a poor insulin administration technique as the 
main cause of skin LH (Thow et al. 1990; Frid and Linden 
1992; Seyoum and Abdulkadir 1996; Hauner et  al. 1996; 
Raile et al. 2001; Kordonouri et al. 2002; Vardar and Kizilci 
2007; Hajheydari et al. 2011) and of their metabolic conse-
quences, including wide blood glucose variability, as well 
as, severe unexplained hypoglycemic episodes (Young 
et al. 1984; Chowdhury and Escudier 2003; Richardson and 
Kerr 2003; Johansson et al. 2005; Gentile et al. 2011). Many 
papers also provide recommendations on how to properly 
inject insulin (Frid et al. 2010). Despite this, the extremely 
wide variation in LH rate reported so far in insulin-treated 
patients (Hauner et al. 1996; McNally et al. 1988; Partanen 
and Rissanen 2000; Raile et al. 2001; Kordonouri et al. 2002; 
Teft 2002; Vardar and Kizilci 2007; Hajheydari et al. 2011; 
Blanco et  al. 2013; Grassi et  al. 2014) proves that no sys-
tematic educational program has been implemented world-
wide to teach people with diabetes how to correctly inject 
insulin (Blanco et al. 2013; Grassi et al. 2014). It also reflects 
the fact that the literature is still lacking a clear, explicit and 
Fig. 2 Lipohyertrophy identification technique. The figure shows 
how to identify a LH lesion after a thorough inspection of the area by 
performing repeated vertical and horizontal finger tip movements 
over and around it (a–c), pinching it (d–f) and marking it (g) and how 
to finally measure it (h)
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standardized methodology describing how to recognize 
and diagnose LH lesions regardless of size, location and 
texture (Seyoum and Abdulkadir 1996; Hauner et al. 1996; 
McNally et al. 1988; Partanen and Rissanen 2000; Raile et al. 
2001; Kordonouri et al. 2002; Teft 2002; Vardar and Kizilci 
2007; Hajheydari et  al. 2011; Blanco et  al. 2013; Grassi 
et  al. 2014). Moreover, despite their fully accepted role in 
the diagnosis of LH, USS are too costly to be proposed for 
Table 3 Lipohypertrophy identification rate for  Well Trained (WT) and  Non-Trained (NT) health professionals by  site, 
shape and size
Overall Site Shape Diameter
Abdomen Arm Thigh Flat Protruding ≤4 cm >4 cm
n = 40 n = 16 n = 14 n = 10 n = 22 n = 18 n = 20 n = 20
WT
 1 40 (100 %) 16 (100 %) 14 (100 %) 10 (100 %) 22 (100 %) 18 (100 %) 20 (100 %) 20 (100 %)
 2 36 (90 %) 16 (100 %) 10 (71 %) 10 (100 %) 18 (82 %) 18 (100 %) 18 (90 %) 18 (90 %)
 3 38 (95 %) 16 (100 %) 12 (86 %) 10 (100 %) 20 (91 %) 18 (100 %) 18 (90 %) 20 (100 %)
 4 40 (100 %) 16 (100 %) 14 (100 %) 10 (100 %) 22 (100 %) 18 (100 %) 20 (100 %) 20 (100 %)
NT
 1 28 (70 %) 14 (88 %) 4 (29 %) 10 (100 %) 10 (46 %) 18 (100 %) 10 (50 %) 18 (90 %)
 2 24 (60 %) 14 (88 %) 4 (29 %) 6 (60 %) 10 (46 %) 14 (78 %) 8 (40 %) 16 (80 %)
 3 32 (80 %) 12 (75 %) 10 (71 %) 10 (100 %) 18 (82 %) 14 (78 %) 16 (80 %) 16 (80 %)
 4 22 (55 %) 14 (88 %) 4 (29 %) 4 (40 %) 8 (36 %) 14 (78 %) 6 (30 %) 16 (80 %)
Fig. 3 Lipohypertrophy identification results obtained by trained and 
non-trained health professionals as referred to the shape, site and size 
of skin lesions (% stays for identification rate)
Table 4 Univariate and  multivariate predictors of  missed 
lipohypertrophy (LH) identification by  well trained (WT) 
and non-trained (NT) health professionals (HPs)
Univariate analysis in the overall group was performed after adjusting for HPs’ 
experience (NT o WT)
Univariate p Multivariate p
NT
 Female gender 1.91 (0.32–11.50) 0.480
 BMI (Kg/m2) 1.29 (0.89–1.87) 0.172 –
 LH site
  Abdomen 1.00 –
  Arm 10.75 (2.11–54.63) 0.004 6.04 (1.11–32.79) 0.037
  Thigh 1.90 (0.34–10.67) 0.467 – 0.999
 LH shape
  Protruding 1.00 –
  Flat 6.27 (1.25–31.62) 0.026 0.84 (0.14–5.20) 0.855
 LH size
  Diameter  
≤4 cm
6.90 (1.34–35.41) 0.021 3.78 (0.92–15.58) 0.066
Overall
 NT versus WT 24.87 (5.69–108.74)<0.001 24.27 (5.58–105.58) <0.001
 Female gender 1.88 (0.31–11.44) 0.492 –
 BMI (Kg/m2) 1.31 (0.91–1.89) 0.150 –
 LH site
  Abdomen 1.00 –
  Arm 12.49 (2.65–58.92) 0.001 7.20 (1.35–38.36) 0.021
  Thigh 1.86 (0.34–10.18) 0.475 –
 LH shape
  Protruding 1.00 –
  Flat 7.11 (1.43–35.29) 0.016 0.92 (0.14–5.84) 0.930
 LH size
  Diameter  
≤4 cm
6.63 (1.24–35.50) 0.027 3.17 (0.78–12.81) 0.106
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routinely clinical examinations (Bianchi and Martinolli 
2007; Lo Presti et al. 2012; Perciun and Mihu 2014).
We were able to show for the first time that a specific 
training involving repeated and well codified maneuvers 
made inexperienced HPs easily acquire diagnostic accu-
racy in identifying LH lesions independent of site, size, 
shape, and even BMI. This kind of training also granted a 
97 % consistency rate among HPs as compared to the gold 
standard represented by skin USS, while the lack of train-
ing was associated with a wide variability and inconsistency 
of identification results. Therefore, we feel like interpreting 
the extremely wide variability in LH frequency reported by 
the literature as the consequence of the lack of a clear defi-
nition of suitable procedures for lesion identification.
An apparent limitation of our study was the relatively 
small number of patients and HPs involved. Neverthe-
less, our sample size was in line with that of many others 
reported in the literature so far as referred to highly spe-
cific endpoints. Moreover it provided statistically signifi-
cant results, thus proving to be large enough for our aim 
(i.e. merely to help identify a straightforward solution for 
a clinically relevant problem).
In conclusion, we propose diabetes teams to follow sys-
tematically the simple above-reported procedure for the 
diagnosis of LH at all insulin shot sites and to get it fur-
ther implemented and hopefully progressively refined in 
large scale studies.
This would have a major impact for patient education 
as WT health professionals might (1) verify whether or 
not their patients inject insulin correctly and, even better, 
(2) make patients really aware of the importance of their 
injection technique and eager to learn how to identify 
their own lesions early enough to prevent poor metabolic 
control (Polak et al. 1996; EADV 2008; Heinemann 2010).
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